Personalized mRNA vaccine plus Keytruda lowers melanoma recurrence risk in Phase 3 trial
A personalized mRNA vaccine plus Keytruda lowers melanoma recurrence risk, Amgen’s Imdelltra plus Imfinzi cuts the risk of death by 58% in small cell lung cancer, and U.S. measles cases reach 4,588.
Justice Department charges 15 in $2 billion Los Angeles health care fraud takedown
The Justice Department charges 15 in a $2 billion Los Angeles health care fraud takedown, a personalized mRNA melanoma vaccine cuts recurrence risk by 42%, and the FDA approves bepirovirsen for hepatitis B.